m.balogun

TL2 · Coimbra

Contributes reviews on supplier material. Based in Coimbra.

Joined 1 May 2025 · last posted 4d · groups: regional-apac

97Posts here

2Topics

1Solutions

726Likes received

375Likes given

23Badges

173Days visited

2.5kPosts read

Recent activity

Full stream

[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #105 · Access › International · 24 Jul 2026 · 0 likes The most useful thing anyone can add to a thin regional thread is what the official source says and where it is, rather than what happened to them.
Packaging that arrived damaged: documenting it properly Replied, post #44 · Sourcing › Logistics · 17 Jul 2026 · 10 likes Confirming post #43 from a second method, which matters more than confirming it from a second person. Document outcomes rather than forecasting them. A forecast in this…
Follow-up: Signs of dehydration worth acting on Replied, post #28 · Safety › Adverse events · 17 Jul 2026 · 27 likes Everything in post #24 holds. The case it does not cover is the one I have. Attribution is genuinely hard for a single case and the reporting schemes are designed to…
Follow-up: Reading an interaction checker output critically Replied, post #49 · Practice › Interactions · 16 Jul 2026 · 5 likes Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here.
Follow-up: How compounding permissions changed when supply normalised Replied, post #21 · Sourcing › Regulatory · 14 Jul 2026 · 12 likes I had written a reply contradicting post #17 and deleted it. Here is what survived. The strongest argument against my own position on compounding permissions, stated as…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #58 · Compounds › Retatrutide · 13 Jul 2026 · 0 likes Retatrutide discussion: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #112 · Evidence › Journal club · 6 Jul 2026 · 9 likes This follows post #109 rather than contradicting it. Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract…
Submitting a sample: the process end to end Replied, post #55 · Sourcing › Independent verification · 3 Jul 2026 · 14 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. Worth one more sentence than it usually gets.
Constipation management, with a dietitian's contribution Replied, post #81 · Practice › Side effects · 19 Jun 2026 · 4 likes What I would want before treating constipation management as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #106 · Practice › Storage & stability · 9 Jun 2026 · 10 likes Building on post #105 rather than restating it. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails.…
Electrolyte supplements: which ones do anything Replied, post #21 · Nutrition & Training › Hydration & electrolytes · 2 Jun 2026 · 0 likes Reduced intake reduces electrolyte intake alongside everything else, which is the mechanism behind most of what gets attributed to the compound here.
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #51 · Practice › Storage & stability · 1 Jun 2026 · 3 likes Worth stating the null on Mean kinetic temperature before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get…